Modulation of the QT interval duration in hypertension with antihypertensive treatment

Area of Science:

• Cardiology
• Pharmacology
• Electrophysiology

Background:

• The QT interval on electrocardiography reflects myocardial repolarization and is crucial for assessing cardiac abnormalities, toxicity, and drug safety.
• In hypertension, a prolonged QT interval predicts increased risk of coronary events and cardiovascular death, even after accounting for other risk factors.

Purpose of the Study:

• To explore the relationship between hypertension, QT interval duration, and the impact of antihypertensive medications.
• To highlight the importance of considering drug-specific effects on QT interval in long-term hypertension management.

Main Methods:

• Review of existing literature on QT interval measurement, hypertension, and antihypertensive drug effects.
• Analysis of mechanisms contributing to QT interval prolongation in hypertensive patients.

Main Results:

• Hypertension is associated with QT interval prolongation, linked to cardiomyocyte hypertrophy, increased left ventricular mass, and altered autonomic nervous system tone.
• Antihypertensive drugs exhibit varied effects on QT interval duration, influenced by their impact on left ventricular mass, autonomic tone, and cardiac ion channel activity.

Conclusions:

• The QT interval is a significant predictor of cardiovascular risk in hypertensive individuals.
• The diverse effects of antihypertensive drugs on QT interval duration necessitate careful consideration in pharmacotherapy selection for hypertension.